(PATH) Uipath - Overview

Sector: Technology | Industry: Software - Infrastructure | Exchange: NYSE (USA) | Market Cap: 5.049m USD | Total Return: -21.4% in 12m

Automation Software, AI Agents, Process Orchestration, Data Extraction
Total Rating 41
Safety 49
Buy Signal 0.40
Software - Infrastructure
Industry Rotation: +27.8
Market Cap: 5.05B
Avg Turnover: 292M
Risk 3d forecast
Volatility54.1%
VaR 5th Pctl8.97%
VaR vs Median0.67%
Reward TTM
Sharpe Ratio-0.16
Rel. Str. IBD15.9
Rel. Str. Peer Group47.3
Character TTM
Beta1.411
Beta Downside1.807
Hurst Exponent0.508
Drawdowns 3y
Max DD65.10%
CAGR/Max DD-0.20
CAGR/Mean DD-0.33
EPS (Earnings per Share) EPS (Earnings per Share) of PATH over the last years for every Quarter: "2021-04": 0.02, "2021-07": 0.01, "2021-10": -0.234, "2022-01": 0.05, "2022-04": -0.03, "2022-07": -0.02, "2022-10": 0.05, "2023-01": 0.15, "2023-04": 0.11, "2023-07": 0.09, "2023-10": 0.12, "2024-01": 0.22, "2024-04": 0.13, "2024-07": 0.04, "2024-10": 0.11, "2025-01": 0.26, "2025-04": 0.11, "2025-07": 0.15, "2025-10": 0.16, "2026-01": 0.3,
EPS CAGR: 147.01%
EPS Trend: 69.3%
Last SUE: 1.56
Qual. Beats: 1
Revenue Revenue of PATH over the last years for every Quarter: 2021-04: 186.217, 2021-07: 195.521, 2021-10: 220.816, 2022-01: 289.698, 2022-04: 245.066, 2022-07: 242.222, 2022-10: 262.744, 2023-01: 308.549, 2023-04: 289.588, 2023-07: 287.31, 2023-10: 325.921, 2024-01: 405.253, 2024-04: 335.112, 2024-07: 316.253, 2024-10: 354.653, 2025-01: 423.646, 2025-04: 356.624, 2025-07: 361.728, 2025-10: 411.113, 2026-01: 481.107,
Rev. CAGR: 19.71%
Rev. Trend: 89.1%
Last SUE: 1.76
Qual. Beats: 4

Warnings

Altman Z'' -0.46 < 1.0 - financial distress zone

Tailwinds

Confidence, Garp

Description: PATH Uipath

UiPath Inc. (PATH) provides an enterprise-grade automation platform designed to integrate AI agents, robotic process automation (RPA), and API-based workflows. The companys suite includes tools for process orchestration, intelligent document extraction, and centralized governance to coordinate tasks across humans and digital workers. Headquartered in New York, the firm serves global clients in heavily regulated industries such as financial services, healthcare, and manufacturing.

The business operates under a software-as-a-service (SaaS) model, generating revenue primarily through recurring subscriptions for its cloud-based and on-premise automation tools. As a leader in the Systems Software sub-industry, UiPath competes in the rapidly evolving Intelligent Automation market, which shifts traditional RPA toward generative AI-driven agentic workflows. To better understand these competitive dynamics and valuation metrics, consider reviewing the detailed financial breakdowns on ValueRay.

Headlines to Watch Out For
  • Transition to agentic AI workflows shifts revenue from legacy RPA to high-margin software
  • Subscription ARR growth remains primary metric for valuation and long-term free cash flow
  • Competitive pressure from Microsoft Power Automate impacts enterprise pricing and market share expansion
  • Global enterprise IT spending cycles dictate pace of large-scale digital transformation contracts
Piotroski VR‑10 (Strict) 6.5
Net Income: 282.3m TTM > 0 and > 6% of Revenue
FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.41 > 1.0
NWC/Revenue: 83.11% < 20% (prev 107.7%; Δ -24.58% < -1%)
CFO/TA 0.12 > 3% & CFO 371.2m > Net Income 282.3m
Net Debt (-1.39b) to EBITDA (74.8m): -18.59 < 3
Current Ratio: 2.48 > 1.5 & < 3
Outstanding Shares: last quarter (545.3m) vs 12m ago -1.82% < -2%
Gross Margin: 83.25% > 18% (prev 0.83%; Δ 8.24k% > 0.5%)
Asset Turnover: 53.29% > 50% (prev 49.90%; Δ 3.39% > 0%)
Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM)
Altman Z'' -0.46
A: 0.42 (Total Current Assets 2.24b - Total Current Liabilities 905.4m) / Total Assets 3.18b
B: -0.54 (Retained Earnings -1.71b / Total Assets 3.18b)
C: 0.02 (EBIT TTM 57.9m / Avg Total Assets 3.02b)
D: -1.52 (Book Value of Equity -1.67b / Total Liabilities 1.10b)
Altman-Z'' Score: -0.46 = B
Beneish M -2.57
DSRI: 0.95 (Receivables 580.7m/542.3m, Revenue 1.61b/1.43b)
GMI: 0.99 (GM 83.25% / 82.69%)
AQI: 1.74 (AQ_t 0.26 / AQ_t-1 0.15)
SGI: 1.13 (Revenue 1.61b / 1.43b)
TATA: -0.03 (NI 282.3m - CFO 371.2m) / TA 3.18b)
Beneish M-Score: -2.57 (Cap -4..+1) = A
What is the price of PATH shares? As of May 18, 2026, the stock is trading at USD 10.27 with a total of 46,654,863 shares traded.
Over the past week, the price has changed by -4.82%, over one month by -3.20%, over three months by -6.12% and over the past year by -21.42%.
Is PATH a buy, sell or hold? Uipath has received a consensus analysts rating of 3.17. Therefor, it is recommend to hold PATH.
  • StrongBuy: 3
  • Buy: 1
  • Hold: 18
  • Sell: 1
  • StrongSell: 1
What are the forecasts/targets for the PATH price?
Analysts Target Price 13.5 31.5%
Uipath (PATH) - Fundamental Data Overview as of 17 May 2026
P/E Trailing = 18.6573
P/E Forward = 13.0039
P/S = 3.3187
P/B = 2.7145
P/EG = 0.3714
Revenue TTM = 1.61b USD
EBIT TTM = 57.9m USD
EBITDA TTM = 74.8m USD
Long Term Debt = 81.2m USD (from capitalLeaseObligations, last quarter)
 Short Term Debt = unknown (none)
 Debt = 81.2m USD (corrected: LT Debt 81.2m + ST Debt none)
Net Debt = -1.39b USD (recalculated: Debt 81.2m - CCE 1.47b)
Enterprise Value = 3.66b USD (5.05b + Debt 81.2m - CCE 1.47b)
 Interest Coverage Ratio = unknown (Ebit TTM 57.9m / Interest Expense TTM 0.0)
 EV/FCF = 10.39x (Enterprise Value 3.66b / FCF TTM 352.2m)
FCF Yield = 9.63% (FCF TTM 352.2m / Enterprise Value 3.66b)
FCF Margin = 21.87% (FCF TTM 352.2m / Revenue TTM 1.61b)
Net Margin = 17.53% (Net Income TTM 282.3m / Revenue TTM 1.61b)
Gross Margin = 83.25% ((Revenue TTM 1.61b - Cost of Revenue TTM 269.8m) / Revenue TTM)
Gross Margin QoQ = 84.88% (prev 83.26%)
Tobins Q-Ratio = 1.15 (Enterprise Value 3.66b / Total Assets 3.18b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 81.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = 45.7m (EBIT 57.9m * (1 - 21.00%))
Current Ratio = 2.48 (Total Current Assets 2.24b / Total Current Liabilities 905.4m)
Debt / Equity = 0.04 (Debt 81.2m / totalStockholderEquity, last quarter 2.08b)
Debt / EBITDA = -18.59 (Net Debt -1.39b / EBITDA 74.8m)
Debt / FCF = -3.95 (Net Debt -1.39b / FCF TTM 352.2m)
Total Stockholder Equity = 1.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.34% (Net Income 282.3m / Total Assets 3.18b)
RoE = 15.32% (Net Income TTM 282.3m / Total Stockholder Equity 1.84b)
RoCE = 3.01% (EBIT 57.9m / Capital Employed (Equity 1.84b + L.T.Debt 81.2m))
RoIC = 2.48% (NOPAT 45.7m / Invested Capital 1.84b)
WACC = 10.77% (E(5.05b)/V(5.13b) * Re(10.94%) + D(81.2m)/V(5.13b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 10.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -68.89 | Cagr: -1.74%
[DCF] Terminal Value 68.84% ; FCFF base≈333.6m ; Y1≈331.3m ; Y5≈346.7m
[DCF] Fair Price = 11.84 (EV 4.01b - Net Debt -1.39b = Equity 5.40b / Shares 455.8m; r=10.77% [WACC]; 5y FCF grow -1.40% → 3.0% )
EPS Correlation: 69.33 | EPS CAGR: 147.0% | SUE: 1.56 | # QB: 1
Revenue Correlation: 89.08 | Revenue CAGR: 19.71% | SUE: 1.76 | # QB: 4
EPS current Quarter (2026-07-31): EPS=0.15 | Chg30d=+7.20% | Revisions=+33% | Analysts=19
EPS current Year (2027-01-31): EPS=0.80 | Chg30d=+0.40% | Revisions=+20% | GrowthEPS=+11.3% | GrowthRev=+9.1%
EPS next Year (2028-01-31): EPS=0.90 | Chg30d=+0.39% | Revisions=+20% | GrowthEPS=+12.2% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: +33%